Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of saffron in the treatment of major depressive disorder with anxious distress
IRCT201501041556N71Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
saffron
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201501041556N71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201501041556N71.